170 related articles for article (PubMed ID: 1395081)
1. X chromosome inactivation patterns in haematopoietic cells of female carriers of X-linked severe combined immunodeficiency determined by methylation analysis at the hypervariable DXS255 locus.
Hendriks RW; Kraakman ME; Schuurman RK
Clin Genet; 1992 Sep; 42(3):114-21. PubMed ID: 1395081
[TBL] [Abstract][Full Text] [Related]
2. Patterns of X chromosome inactivation in haematopoietic cells of female carriers of X linked severe combined immunodeficiency.
Hendriks RW; Kraakman ME; Schuurman RK
Immunodeficiency; 1993; 4(1-4):263-5. PubMed ID: 8167715
[TBL] [Abstract][Full Text] [Related]
3. Maximum-likelihood analysis of human T-cell X chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency.
Puck JM; Stewart CC; Nussbaum RL
Am J Hum Genet; 1992 Apr; 50(4):742-8. PubMed ID: 1550118
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of Wiskott-Aldrich syndrome by analysis of the X chromosome inactivation patterns in maternal leucocyte populations using the hypervariable DXS255 locus.
Hendriks RW; De Weers M; Mensink RG; Kraakman ME; Mollee-Versteegde IF; Veerman AJ; Sandkuyl LA; Schuurman RK
Clin Exp Immunol; 1991 May; 84(2):219-22. PubMed ID: 1709069
[TBL] [Abstract][Full Text] [Related]
5. Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation.
Puck JM; Nussbaum RL; Conley ME
J Clin Invest; 1987 May; 79(5):1395-400. PubMed ID: 2883199
[TBL] [Abstract][Full Text] [Related]
6. Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency.
Wengler GS; Allen RC; Parolini O; Smith H; Conley ME
J Immunol; 1993 Jan; 150(2):700-4. PubMed ID: 8093460
[TBL] [Abstract][Full Text] [Related]
7. Carrier detection in X-linked immunodeficiencies. II: An X inactivation assay based on differential methylation of a line-1 repeat at the DXS255 locus.
Hinds H; Craig IW; Chen ZY; Kraakman ME; Schuurman RK; Hendriks RW
Immunodeficiency; 1993; 4(1-4):213-5. PubMed ID: 8167703
[TBL] [Abstract][Full Text] [Related]
8. Use of X chromosome inactivation analysis to establish carrier status for X-linked severe combined immunodeficiency.
Goodship J; Malcolm S; Lau YL; Pembrey ME; Levinsky RJ
Lancet; 1988 Apr; 1(8588):729-32. PubMed ID: 2895261
[TBL] [Abstract][Full Text] [Related]
9. Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.
Conley ME; Lavoie A; Briggs C; Brown P; Guerra C; Puck JM
Proc Natl Acad Sci U S A; 1988 May; 85(9):3090-4. PubMed ID: 2896355
[TBL] [Abstract][Full Text] [Related]
10. Carrier identification in X-linked immunodeficiency diseases.
Li SL; Ting SS; Lindeman R; Ffrench R; Ziegler JB
J Paediatr Child Health; 1998 Jun; 34(3):273-9. PubMed ID: 9633977
[TBL] [Abstract][Full Text] [Related]
11. Evidence that X-linked severe combined immunodeficiency is not a differentiation defect of T lymphocytes.
Goodship J; Malcolm S; Levinsky RJ
Clin Exp Immunol; 1991 Jan; 83(1):4-9. PubMed ID: 1988230
[TBL] [Abstract][Full Text] [Related]
12. Differential methylation at the 5' and the 3' CCGG sites flanking the X chromosomal hypervariable DXS255 locus.
Hendriks RW; Kraakman ME; Mensink RG; Schuurman RK
Hum Genet; 1991 Nov; 88(1):105-11. PubMed ID: 1959916
[TBL] [Abstract][Full Text] [Related]
13. Carrier detection in Wiskott-Aldrich syndrome: combined use of M27 beta for X-inactivation studies and as a linked probe.
Goodship J; Carter J; Espanol T; Boyd Y; Malcolm S; Levinsky RJ
Blood; 1991 Jun; 77(12):2677-81. PubMed ID: 2043768
[TBL] [Abstract][Full Text] [Related]
14. Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency.
Schmalstieg FC; Leonard WJ; Noguchi M; Berg M; Rudloff HE; Denney RM; Dave SK; Brooks EG; Goldman AS
J Clin Invest; 1995 Mar; 95(3):1169-73. PubMed ID: 7883965
[TBL] [Abstract][Full Text] [Related]
15. Methylation patterns at the hypervariable X-chromosome locus DXS255 (M27 beta): correlation with X-inactivation status.
Boyd Y; Fraser NJ
Genomics; 1990 Jun; 7(2):182-7. PubMed ID: 1693357
[TBL] [Abstract][Full Text] [Related]
16. Evidence that in X-linked immunodeficiency with hyperimmunoglobulinemia M the intrinsic immunoglobulin heavy chain class switch mechanism is intact.
Hendriks RW; Kraakman ME; Craig IW; Espanol T; Schuurman RK
Eur J Immunol; 1990 Dec; 20(12):2603-8. PubMed ID: 1980111
[TBL] [Abstract][Full Text] [Related]
17. Methylation of the DXS255 hypervariable locus 5' CCGG site may be affected by factors other than X-chromosome activation status.
Cachia PG; Culligan DJ; Thomas ED; Whittaker J; Jacobs A; Padua RA
Genomics; 1992 Sep; 14(1):70-4. PubMed ID: 1358800
[TBL] [Abstract][Full Text] [Related]
18. Carrier detection in the Wiskott Aldrich syndrome.
Fearon ER; Kohn DB; Winkelstein JA; Vogelstein B; Blaese RM
Blood; 1988 Nov; 72(5):1735-9. PubMed ID: 3263154
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans.
Noguchi M; Yi H; Rosenblatt HM; Filipovich AH; Adelstein S; Modi WS; McBride OW; Leonard WJ
Cell; 1993 Apr; 73(1):147-57. PubMed ID: 8462096
[TBL] [Abstract][Full Text] [Related]
20. Carrier detection in typical and atypical X-linked agammaglobulinemia.
Conley ME; Puck JM
J Pediatr; 1988 May; 112(5):688-94. PubMed ID: 2896233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
